Furthermore, the subcutaneous injection of BRD4 degrader ARV-771 in xenograft tumor mice causes noticeable skin discoloration (Raina et al., 2016), which is consistent with the phenotype of Brd4 depleted mice (Bolden et al., 2014). Here, BRD4 is linked to neoplasm.